Whitehouse Station, N.J.-based Merck (MRK) - Get Report reported a profit on Tuesday of $1.64 billion, or 78 cents per share, beating out analysts predictions of earnings per share of 74 cents and revenue of $5.98 billion. The maker of numerous drugs, including Singulair, Zostavax and Fosamax, credits restricting and lower fourth-quarter costs for materials and production with boosting the bottom line.
This piece of earnings news along with a surprising spike in pending home sales in December gave the market a nice lift on Tuesday, led by such stocks as
But will this be enough?
With this in mind, we thought we'd take a look at some of the stocks people have been searching for on
and see what
To read more,
Stockpickr is a wholly owned subsidiary of TheStreet.com.